These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 11245466)
21. Identification of naturally processed CD8 T cell epitopes from prostein, a prostate tissue-specific vaccine candidate. Friedman RS; Spies AG; Kalos M Eur J Immunol; 2004 Apr; 34(4):1091-101. PubMed ID: 15048720 [TBL] [Abstract][Full Text] [Related]
22. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Xu LL; Stackhouse BG; Florence K; Zhang W; Shanmugam N; Sesterhenn IA; Zou Z; Srikantan V; Augustus M; Roschke V; Carter K; McLeod DG; Moul JW; Soppett D; Srivastava S Cancer Res; 2000 Dec; 60(23):6568-72. PubMed ID: 11118034 [TBL] [Abstract][Full Text] [Related]
23. Molecular cloning and characterization of Strabismus 2 (STB2). Katoh M Int J Oncol; 2002 May; 20(5):993-8. PubMed ID: 11956595 [TBL] [Abstract][Full Text] [Related]
24. High expression of a new marker PCA-1 in human prostate carcinoma. Konishi N; Nakamura M; Ishida E; Shimada K; Mitsui E; Yoshikawa R; Yamamoto H; Tsujikawa K Clin Cancer Res; 2005 Jul; 11(14):5090-7. PubMed ID: 16033822 [TBL] [Abstract][Full Text] [Related]
25. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Srikantan V; Zou Z; Petrovics G; Xu L; Augustus M; Davis L; Livezey JR; Connell T; Sesterhenn IA; Yoshino K; Buzard GS; Mostofi FK; McLeod DG; Moul JW; Srivastava S Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12216-21. PubMed ID: 11050243 [TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of PLZF as a prostatic androgen-responsive gene. Jiang F; Wang Z Prostate; 2004 Jun; 59(4):426-35. PubMed ID: 15065091 [TBL] [Abstract][Full Text] [Related]
27. Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer. Korkmaz CG; Korkmaz KS; Kurys P; Elbi C; Wang L; Klokk TI; Hammarstrom C; Troen G; Svindland A; Hager GL; Saatcioglu F Oncogene; 2005 Jul; 24(31):4934-45. PubMed ID: 15897894 [TBL] [Abstract][Full Text] [Related]
28. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells. Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946 [TBL] [Abstract][Full Text] [Related]
29. CLAR1, a novel gene that exhibits enhanced expression in advanced human prostate cancer. Rondinelli RH; Tricoli JV Clin Cancer Res; 1999 Jun; 5(6):1595-602. PubMed ID: 10389949 [TBL] [Abstract][Full Text] [Related]
30. Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. Tepper CG; Boucher DL; Ryan PE; Ma AH; Xia L; Lee LF; Pretlow TG; Kung HJ Cancer Res; 2002 Nov; 62(22):6606-14. PubMed ID: 12438256 [TBL] [Abstract][Full Text] [Related]
31. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Xu J; Stolk JA; Zhang X; Silva SJ; Houghton RL; Matsumura M; Vedvick TS; Leslie KB; Badaro R; Reed SG Cancer Res; 2000 Mar; 60(6):1677-82. PubMed ID: 10749139 [TBL] [Abstract][Full Text] [Related]
32. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996 [TBL] [Abstract][Full Text] [Related]
33. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735 [TBL] [Abstract][Full Text] [Related]
34. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction. Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642 [TBL] [Abstract][Full Text] [Related]
35. D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate. Weigle B; Fuessel S; Ebner R; Temme A; Schmitz M; Schwind S; Kiessling A; Rieger MA; Meye A; Bachmann M; Wirth MP; Rieber EP Biochem Biophys Res Commun; 2004 Sep; 322(1):239-49. PubMed ID: 15313197 [TBL] [Abstract][Full Text] [Related]
36. LAPTM5: a novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells. Adra CN; Zhu S; Ko JL; Guillemot JC; Cuervo AM; Kobayashi H; Horiuchi T; Lelias JM; Rowley JD; Lim B Genomics; 1996 Jul; 35(2):328-37. PubMed ID: 8661146 [TBL] [Abstract][Full Text] [Related]
37. Identification of a novel prostate cancer-associated tumor antigen. Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878 [TBL] [Abstract][Full Text] [Related]
38. Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma. Wang-Johanning F; Frost AR; Jian B; Azerou R; Lu DW; Chen DT; Johanning GL Cancer; 2003 Jul; 98(1):187-97. PubMed ID: 12833471 [TBL] [Abstract][Full Text] [Related]
39. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Kwabi-Addo B; Wang J; Erdem H; Vaid A; Castro P; Ayala G; Ittmann M Cancer Res; 2004 Jul; 64(14):4728-35. PubMed ID: 15256439 [TBL] [Abstract][Full Text] [Related]